BRAF and epilepsy: For example, the frequency and severity of epilepsies were higher in individuals with BRAF or MAP2K1 variants (especially variants in the catalytic protein kinase domain of BRAF and p.Y130 site of MAP2K1) than in those with MAP2K2 variants [14].